{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:08:29Z","timestamp":1786993709462,"version":"build-2736575974"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,22]],"date-time":"2024-08-22T00:00:00Z","timestamp":1724284800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100020377","name":"Macquarie Group Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100020377","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["RG220260"],"award-info":[{"award-number":["RG220260"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Regional Health - Western Pacific"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.lanwpc.2024.101194","type":"journal-article","created":{"date-parts":[[2024,9,4]],"date-time":"2024-09-04T11:07:28Z","timestamp":1725448048000},"page":"101194","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Acceptability of a nationwide scabies mass drug administration (MDA) program in Fiji: a qualitative interview-based study"],"prefix":"10.1016","volume":"51","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3048-4160","authenticated-orcid":false,"given":"Elke","family":"Mitchell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aminiasi","family":"Tavui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Andersson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanna","family":"Lake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aminiasi","family":"Koroivueti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josefa","family":"Koroivueta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ripeka","family":"Kaurasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinaisi","family":"Bechu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Kaldor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Steer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9038-5300","authenticated-orcid":false,"given":"Lucia","family":"Romani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lanwpc.2024.101194_bib1","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/S0140-6736(17)32154-2","article-title":"Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990-2016: a systematic analysis for the global burden of disease study 2016","volume":"390","author":"Vos","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.lanwpc.2024.101194_bib2","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/S1473-3099(15)00132-2","article-title":"Prevalence of scabies and impetigo worldwide: a systematic review","volume":"15","author":"Romani","year":"2015","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.lanwpc.2024.101194_bib3","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0140-6736(19)31136-5","article-title":"The public health control of scabies: priorities for research and action","volume":"394","author":"Engelman","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.lanwpc.2024.101194_bib4","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0003452","article-title":"Scabies and impetigo prevalence and risk factors in Fiji: a national survey","volume":"9","author":"Romani","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.lanwpc.2024.101194_bib5","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1097\/QCO.0b013e3283511d27","article-title":"Streptococcal skin infection and rheumatic heart disease","volume":"25","author":"Parks","year":"2012","journal-title":"Curr Opin Infect Dis"},{"key":"10.1016\/j.lanwpc.2024.101194_bib6","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0008825","article-title":"Community perspectives on scabies, impetigo and mass drug administration in Fiji: a qualitative study","volume":"14","author":"Mitchell","year":"2020","journal-title":"PLoS Neglected Trop Dis"},{"key":"10.1016\/j.lanwpc.2024.101194_bib7","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0007182","article-title":"A\u00a0systematic review of scabies transmission models and data to evaluate the cost-effectiveness of scabies interventions","volume":"13","author":"van der Linden","year":"2019","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.lanwpc.2024.101194_bib8","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/j.1365-4632.2011.05017.x","article-title":"Impaired quality of life in adults and children with scabies from an impoverished community in Brazil","volume":"51","author":"Worth","year":"2012","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.lanwpc.2024.101194_bib9","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1056\/NEJMoa1500987","article-title":"Mass drug administration for scabies control in a population with endemic disease","volume":"373","author":"Romani","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.lanwpc.2024.101194_bib10","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0002586","article-title":"Impact of six rounds of mass drug administration on brugian filariasis and soil-transmitted helminth infections in eastern Indonesia","volume":"7","author":"Supali","year":"2013","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.lanwpc.2024.101194_bib11","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1038\/clpt.2009.16","article-title":"Mass drug administration and integrated control for the world's high-prevalence neglected tropical diseases","volume":"85","author":"Hotez","year":"2009","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.lanwpc.2024.101194_bib12","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/S1473-3099(18)30790-4","article-title":"Efficacy of mass drug administration with ivermectin for control of scabies and impetigo, with coadministration of azithromycin: a single-arm community intervention trial","volume":"19","author":"Romani","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.lanwpc.2024.101194_bib13","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1093\/cid\/ciy574","article-title":"Randomized trial of community treatment with azithromycin and ivermectin mass drug administration for control of scabies and impetigo","volume":"68","author":"Marks","year":"2019","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.lanwpc.2024.101194_bib14","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0009661","article-title":"A\u00a0framework for scabies control","volume":"15","author":"Engelman","year":"2021","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.lanwpc.2024.101194_bib15","doi-asserted-by":"crossref","first-page":"845","DOI":"10.4269\/ajtmh.16-0753","article-title":"The epidemiology of scabies and impetigo in relation to demographic and residential characteristics: baseline findings from the skin health intervention Fiji trial","volume":"97","author":"Romani","year":"2017","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.lanwpc.2024.101194_bib16","first-page":"100433","article-title":"Prevention of bacterial complications of scabies using mass drug administration: a population-based, before-after trial in Fiji, 2018-2020","volume":"22","author":"Thean","year":"2022","journal-title":"Lancet Reg Health West Pac"},{"key":"10.1016\/j.lanwpc.2024.101194_bib17","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0010215","article-title":"Community perceptions and acceptability of mass drug administration for the control of neglected tropical diseases in Asia-Pacific countries: a systematic scoping review of qualitative research","volume":"16","author":"Mitchell","year":"2022","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.lanwpc.2024.101194_bib18","series-title":"The republic of Fiji: vital statistics report 2016-2021","year":"2023"},{"key":"10.1016\/j.lanwpc.2024.101194_bib19","series-title":"2017 population and housing census","year":"2018"},{"key":"10.1016\/j.lanwpc.2024.101194_bib20","series-title":"Monitoring and evaluation in health and social development","first-page":"1","article-title":"Interpretative and ethnographic perspectives: alternative approaches to monitoring and evaluation practice","author":"Bell","year":"2016"},{"key":"10.1016\/j.lanwpc.2024.101194_bib21","series-title":"Qualitative research and evaluation methods","author":"Patton","year":"2002"},{"key":"10.1016\/j.lanwpc.2024.101194_bib22","series-title":"Basics of qualitative research","author":"Strauss","year":"1990"},{"key":"10.1016\/j.lanwpc.2024.101194_bib23","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1177\/109019818801500401","article-title":"An ecological perspective on health promotion programs","volume":"15","author":"McLeroy","year":"1988","journal-title":"Health Educ Q"},{"key":"10.1016\/j.lanwpc.2024.101194_bib24","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1191\/1478088706qp063oa","article-title":"Using thematic analysis in psychology","volume":"3","author":"Braun","year":"2006","journal-title":"Qual Res Psychol"},{"key":"10.1016\/j.lanwpc.2024.101194_bib25","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1016\/S1473-3099(21)00630-7","article-title":"Long-term consequences of the misuse of ivermectin data","volume":"21","author":"Alvarez-Moreno","year":"2021","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.lanwpc.2024.101194_bib26","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/s12879-022-07084-0","article-title":"COVID-19 related perception among some community members and frontline healthcare providers for NTD control in Ghana","volume":"22","author":"Ahorlu","year":"2022","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.lanwpc.2024.101194_bib27","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/j.trstmh.2008.05.023","article-title":"Mass drug administration under the programme to eliminate lymphatic filariasis in Orissa, India: a mixed-methods study to identify factors associated with compliance and non-compliance","volume":"102","author":"Babu","year":"2008","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.lanwpc.2024.101194_bib28","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1093\/heapol\/czr048","article-title":"Causal chain mapping: a novel method to analyse treatment compliance decisions relating to lymphatic filariasis elimination in Alor, Indonesia","volume":"27","author":"Krentel","year":"2012","journal-title":"Health Policy Plan"},{"key":"10.1016\/j.lanwpc.2024.101194_bib29","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0005027","article-title":"Improving coverage and compliance in mass drug administration for the elimination of LF in two \u2018Endgame\u2019 districts in Indonesia using micronarrative surveys","volume":"10","author":"Krentel","year":"2016","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.lanwpc.2024.101194_bib30","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0008857","article-title":"Mass administration of medicines in changing contexts: acceptability, adaptability and community directed approaches in Kaduna and Ogun States, Nigeria","volume":"14","author":"Adekeye","year":"2020","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.lanwpc.2024.101194_bib31","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0011213","article-title":"Community perception of school-based mass drug administration program for soil-transmitted helminths and Schistosomiasis in Ogun State, Nigeria","volume":"17","author":"Akinsolu","year":"2023","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.lanwpc.2024.101194_bib32","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1111\/j.1365-3156.2004.01247.x","article-title":"Coverage, compliance and some operational issues of mass drug administration during the programme to eliminate lymphatic filariasis in Orissa, India","volume":"9","author":"Babu","year":"2004","journal-title":"Trop Med Int Health"},{"key":"10.1016\/j.lanwpc.2024.101194_bib33","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1057\/s41271-019-00182-5","article-title":"Gaps and barriers in interventions for the control of soil-transmitted helminthiasis among school-age children in an endemic area of the Philippines: a school-based point-of-view","volume":"40","author":"Labana","year":"2019","journal-title":"J\u00a0Public Health Policy"},{"key":"10.1016\/j.lanwpc.2024.101194_bib34","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0004954","article-title":"Controlling neglected tropical diseases (NTDs) in Haiti: implementation strategies and evidence of their success","volume":"10","author":"Lemoine","year":"2016","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.lanwpc.2024.101194_bib35","doi-asserted-by":"crossref","first-page":"3009","DOI":"10.4103\/jfmpc.jfmpc_503_19","article-title":"Coverage of mass drug administration for elimination of lymphatic filariasis in urban Nagpur, Central India: a mixed method study","volume":"8","author":"Banerjee","year":"2019","journal-title":"J\u00a0Family Med Prim Care"},{"key":"10.1016\/j.lanwpc.2024.101194_bib36","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0083413","article-title":"Increasing coverage in mass drug administration for lymphatic filariasis elimination in an urban setting: a study of Malindi Town, Kenya","volume":"9","author":"Njomo","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.lanwpc.2024.101194_bib37","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0008258","article-title":"Implementer and recipient perspectives of community-wide mass drug administration for soil-transmitted helminths in Kwale County, Kenya","volume":"14","author":"Legge","year":"2020","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.lanwpc.2024.101194_bib38","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.socscimed.2014.09.030","article-title":"Controlling parasites, understanding practices: the biosocial complexity of a one health intervention for neglected zoonotic helminths in northern Lao PDR","volume":"120","author":"Bardosh","year":"2014","journal-title":"Soc Sci Med"},{"key":"10.1016\/j.lanwpc.2024.101194_bib39","first-page":"122","article-title":"Eliminating neglected tropical diseases in urban areas: a review of challenges, strategies and research directions for successful mass drug administration","volume":"3","author":"Adams","year":"2018","journal-title":"Trop Med Infect Dis"}],"container-title":["The Lancet Regional Health - Western Pacific"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666606524001883?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666606524001883?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T08:54:48Z","timestamp":1778921688000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666606524001883"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":39,"alternative-id":["S2666606524001883"],"URL":"https:\/\/doi.org\/10.1016\/j.lanwpc.2024.101194","relation":{},"ISSN":["2666-6065"],"issn-type":[{"value":"2666-6065","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Acceptability of a nationwide scabies mass drug administration (MDA) program in Fiji: a qualitative interview-based study","name":"articletitle","label":"Article Title"},{"value":"The Lancet Regional Health - Western Pacific","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lanwpc.2024.101194","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101194"}}